Photorefraction Screening Plus Atropine Treatment for Myopia is Cost-Effective: A Proof-of-Concept Markov Analysis

PURPOSE: The prevalence of myopia is increasing globally, putting individuals at risk of myopia-associated visual impairment. Low-dose atropine eye drops have been found to safely reduce the risk of progression from myopia to higher levels of myopia and pathological states. In New Zealand, school ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Chuen Yen, Boyd, Matt, Wilson, Graham, Hong, Sheng Chiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205435/
https://www.ncbi.nlm.nih.gov/pubmed/35720738
http://dx.doi.org/10.2147/OPTH.S362342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205435/
https://www.ncbi.nlm.nih.gov/pubmed/35720738
http://dx.doi.org/10.2147/OPTH.S362342

Ejemplares similares